Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
biotech
bluebird bio
1
×
boston
boston blog main
boston top stories
1
×
clinical trials
duchenne muscular dystrophy
dyne therapeutics
facioscapulohumeral muscular dystrophy
1
×
gene therapy
joshua brumm
kaleido biosciences
life sciences
muscular dystrophy
myotonic dystrophy type 1
national blog main
national top stories
new york blog main
rare disease drugs
romesh subramanian
san diego blog main
san francisco blog main
susanna high
vertex pharmaceuticals
What
ago
1
×
biotechs
considering
data
1
×
diseases
drug
dyne
early
expected
experimental
eyes
genetic
having
humans
ipo
ipos
long
medicines
muscle
rare
reach
therapeutics
worked
Language
unset
Current search:
ago
×
data
×
" boston top stories "
×
" bluebird bio "
×
" facioscapulohumeral muscular dystrophy "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases